Nivolumab plus docetaxel in patients with chemotherapy-naïve metastatic castration-resistant prostate cancer: results from the phase II CheckMate 9KD trial
Titel:
Nivolumab plus docetaxel in patients with chemotherapy-naïve metastatic castration-resistant prostate cancer: results from the phase II CheckMate 9KD trial
Auteur:
Fizazi, Karim González Mella, Pablo Castellano, Daniel Minatta, Jose N. Rezazadeh Kalebasty, Arash Shaffer, David Vázquez Limón, Juan C. Sánchez López, Héctor M. Armstrong, Andrew J. Horvath, Lisa Bastos, Diogo A. Amin, Neha P. Li, Jia Unsal-Kacmaz, Keziban Retz, Margitta Saad, Fred Petrylak, Daniel P. Pachynski, Russell K.